Trials / Completed
CompletedNCT02992145
Androgens Level in the Third Trimester of Pregnancy in Patients With Preeclampsia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 80 (actual)
- Sponsor
- Ain Shams Maternity Hospital · Academic / Other
- Sex
- Female
- Age
- 20 Years – 35 Years
- Healthy volunteers
- Not accepted
Summary
This study aims to compare between androgens level (serum total and free testosterone) in women with preeclampsia and normal ones in the third trimester of pregnancy (28-40 weeks).
Detailed description
Methodology: All women in this study will be subjected to: * All women are candidates for this study according to inclusion and exclusion criteria. * History taking with special emphases on last menstrual period to determine the exact Gestational age. * A reliable date is defined as the occurrence of regular menstrual cycles (28±7 days) in patients who have not taken oral contraceptives during the three months before conception and have no irregular bleeding. * General and abdominal examination for each patient to determine those patients matching with the inclusion criteria. * Preeclampsia refers to the new onset of hypertension (systolic blood pressure ≥140 mmHg ,or diastolic blood pressure≥ 90 mmHg ,or both, measured on two occasions \> 6 hours apart) and either proteinuria or end organ dysfunction after 20 weeks of gestation in a previously normotensive woman. * At Ain Shams University Hospitals, the investigator will use ELISA based test system intended for the quantitative measurement of total and free testosterone for patients of both groups.
Conditions
Timeline
- Start date
- 2016-03-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2016-12-14
- Last updated
- 2016-12-16
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT02992145. Inclusion in this directory is not an endorsement.